Fig. 6

Effect of empagliflozin treatment on the expression level of eNOS (a), VCAM-1 (b), TF (c), SGLT1 (d) and SGLT2 (e) in segments of the AOC and in those of the AIC of the lean control and ZSF1 groups as assessed by Western blot analysis. Results are shown as representative immunoblots (upper panels) and corresponding cumulative data (lower panels). Values are shown as mean ± SEM of n = 3–4 per group. *P < 0.05 vs AOC of control group and ^#P < 0.05 vs AIC of control group